SGLT-2 Inhibitors versus GLP-1 Receptor Agonists for Dementia and Depression in Type 2 Diabetes Mellitus: A Meta-Analysis
Diabetes, metabolic syndrome and obesity : targets and therapy · 2026 · Pan R, Wang B, Li Y et
MH
By Maren Holt · Senior Reporter, GLP-1
Nov 1 19:00 ETSource: Diabetes, metabolic syndrome and obesity : targets and therapy
From the source
Read at pubmed.ncbi.nlm.nih.govSGLT-2 Inhibitors versus GLP-1 Receptor Agonists for Dementia and Depression in Type 2 Diabetes Mellitus: A Meta-Analysis
Diabetes, metabolic syndrome and obesity : targets and therapy · 2026 · Pan R, Wang B, Li Y et al.
Source URL https://pubmed.ncbi.nlm.nih.gov/42997476/
